✦ LIBER ✦

Heterogeneity of morphological, cytochemical, and cytogenetic features in the blastic phase of chronic granulocytic leukemia

✍ Scribed by Michael T. Shaw; Richard H. Bottomley; Petre N. Grozea; Robert E. Nordquist

Publisher: John Wiley and Sons
Year: 1975
Tongue: English
Weight: 752 KB
Volume: 35
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197501)35:1<199::aid-cncr2820350124>3.0.co;2-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I–II trial of VP-16 in the treatme

Phase I–II trial of VP-16 in the treatment of acute nonlymphocytic leukemia and blast crisis of chronic granulocytic leukemia

✍ Mailliard, James A. ;Letendre, Louis ;Dalton, Robert J. ;Levitt, Ralph ;Gerstner 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB

VP-16 was used to treat newly diagnosed elderly ( 2 6 5 yr) patients with acute nonlymphocytic leukemia (ANLL) and patients with blast crisis of chronic granulocytic leukemia (BI-CGL). Our pilot study indicated that VP-I6 160 mg/m2 intravenously daily for 5 days was well tolerated and suggested a di

Terminal deoxynucleotidyl transferase in

Terminal deoxynucleotidyl transferase in the blastic phase of chronic myelogenous leukemia: An indicator of response to vincristine and prednisone therapy

✍ Masao Tanaka; Tsuguhiro Kaneda; Yutaka Hirota; Shonen Yoshida; Koichi Kitajima 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 393 KB 👁 1 views

Dual-color flow cytometric analysis of m

Dual-color flow cytometric analysis of megakaryocytic DNA ploidy in the investigation of blastic phase chronic myelogenous leukemia with rearrangement of 3q26

✍ Y. L. Kwong; E. P. Robertson; C. P. Lee; L. C. Chan 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 567 KB

Chronic myelogenous leukemia in nonlymph

Chronic myelogenous leukemia in nonlymphoid blastic phase : Analysis of the results of first salvage therapy with three different treatment approaches for 162 patients

✍ Stefano Sacchi; Hagop M. Kantarjian; Susan O'Brien; Jorge Cortes; Mary Beth Rios 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 2 views

## BACKGROUND. The prognoses of patients with chronic myelogenous leukemia in blastic phase (CML-BP) are extremely poor. Treatment of patients with nonlymphoid CML-BP is associated with very low response rates, a median survival of 2-3 months, and significant toxicities. The aim of this study was

Complete hematologic and cytogenetic res

Complete hematologic and cytogenetic response to 2-amino-9-β-D-arabinosyl-6-methoxy-9H-guanine in a patient with chronic myelogeneous leukemia in T-cell blastic phase : A case report and review of the literature

✍ Alvaro Aguayo; Jorge E. Cortes; Hagop M. Kantarjian; Miloslav Beran; Varsha Gand 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 1 views

## BACKGROUND. T-cell lymphoid blastic phase (BP) transformation is rare in chronic myelogenous leukemia (CML). 2-amino-9-␤-D-arabinosyl-6-methoxy-9H-guanine (GW506U78), a prodrug of arabinosylguanine (ara-G), is effective in T-cell leukemias. ## METHODS. The authors present a case of a 48-year